Mannkind (MNKD) Change in Acquisitions & Divestments (2011 - 2026)
Mannkind (MNKD) reported Change in Acquisitions & Divestments of $30.9 million for Q1 2026, down 38.67% year-over-year from $50.4 million in Q1 2025, and down 56.77% quarter-over-quarter from $71.5 million in Q4 2025.
Mannkind (MNKD) Change in Acquisitions & Divestments (2011 - 2026) Analysis & Trends
Mannkind (MNKD) has 9 years of Change in Acquisitions & Divestments data on file, last reported at $30.9 million in Q1 2026.
- Change in Acquisitions & Divestments for Q1 2026 came in at $30.9 million, down 38.67% year-over-year; the trailing twelve-month figure through Mar 2026 was $195.8 million (up 126.25% YoY), and the FY2025 annual result was $215.3 million, up 270.42% from the prior year.
- Change in Acquisitions & Divestments eased to $30.9 million in Q1 2026 per MNKD's latest filing, from $71.5 million in the prior quarter.
- Over five years, Change in Acquisitions & Divestments peaked at $71.5 million in Q4 2025 and troughed at -$77.2 million in Q4 2024.
- A 5-year average of $31.2 million and a median of $29.3 million in 2022 frame the typical range for Change in Acquisitions & Divestments.
- The sharpest annual moves came in 2022 and 2024: Change in Acquisitions & Divestments soared 892200.0% in 2022, then plunged 390.65% in 2024.
- A 5-year view of Change in Acquisitions & Divestments shows it stood at $24.8 million in 2022, then climbed by 7.28% to $26.6 million in 2023, then sank by 390.65% to -$77.2 million in 2024, then surged by 192.62% to $71.5 million in 2025, then slumped by 56.77% to $30.9 million in 2026.
- Business Quant data shows MNKD's Change in Acquisitions & Divestments at $30.9 million in Q1 2026, $71.5 million in Q4 2025, and $42.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Mannkind | 1.21 Bn | 1.08 Bn | 82.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 30.91 Mn |
| Mar 31, 2026 | 30.91 Mn |
| Dec 31, 2025 | 71.50 Mn |
| Dec 31, 2025 | 71.50 Mn |
| Sep 30, 2025 | 42.02 Mn |
| Sep 30, 2025 | 42.02 Mn |
| Jun 30, 2025 | 51.40 Mn |
| Jun 30, 2025 | 51.40 Mn |
| Mar 31, 2025 | 50.40 Mn |
| Mar 31, 2025 | 50.40 Mn |
| Dec 31, 2024 | -77.19 Mn |
| Dec 31, 2024 | -77.19 Mn |
| Sep 30, 2024 | 46.50 Mn |
| Sep 30, 2024 | 46.50 Mn |
| Jun 30, 2024 | 66.84 Mn |
| Jun 30, 2024 | 66.84 Mn |
| Mar 31, 2024 | 21.97 Mn |
| Mar 31, 2024 | 21.97 Mn |
| Dec 31, 2023 | 26.56 Mn |
| Dec 31, 2023 | 26.56 Mn |